Comparative clinical study on the efficacy of Devadarvadi kashaya tablet and Ashotone tablet in Sutika wellbeing.

Parul Institute of Ayurved0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Primi or Multipara (upto G2) with full term normal delivery (Beyond 37 weeks of
•gestational), who are willing to take part in the study and ready to sign informed
•written consent form.
•Women who delivered with or without Episiotomy.
•Even preterm delivery beyond 32 weeks, subjects with anemia >7gms %, history of Sickle Cell anemia, instrumental/ Vacuum deliveries will be incorporated.

•1. Women who delivered with the lower segment caesarian section.
•2. Parturient with history of eclampsia or PPH.
•3. Patient with history of hyper/hypotension, hyper/hypoglycemia or any other chronic systemic disease.
•4. Women with Thyroid dysfunction during pregnancy or gestational diabetes mellitus or IUD or Still birth or APH.
•5. Severe anemia (Ã¢â?°Â¤7 gm/dl).

发起方

Parul Institute of Ayurved